Global Erectile Dysfunction Drugs Market Projected to Reach USD 2,687.6 Million By 2026

02-Nov-2020 | Facts and Factors

Findings from Facts and Factors has authored “Erectile Dysfunction Drugs Market by Drug Type (Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others), By Mode of Administration (Oral Medications, Topical Medications, Injections, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” states that the global Erectile Dysfunction Drugs market in 2019 is approximately USD 1,923.3 Million. The market is anticipated to grow at a CAGR of 5.0% and is projected to reach around USD 2,687.6 Million by 2026.

Erectile dysfunction or disorder (ED) is the inability to develop and maintain an erection for satisfactory sexual intercourse or activity. Erectile dysfunction or erectile disorders are the preferred terms as opposed to impotence. There are no uniform criteria defining how consistent the problem has to be and for what duration it must be present to considered ED. The emergence of several unique formulations of erectile dysfunction drugs such as topical gels, injectables, and suppositories is expected to widen the scope of treatment for erectile dysfunction.

Browse the full “Erectile Dysfunction Drugs Market by Drug Type (Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others), By Mode of Administration (Oral Medications, Topical Medications, Injections, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026" report at https://www.fnfresearch.com/erectile-dysfunction-drugs-market

The global Erectile DysfunctionDrugs market is driving due to increased vascular disorders followed by the aging population across the world. Furthermore, rising psychological problems, followed by chronic diseases like diabetes, alcohol, and smoking habits are also considered as one of the major driving factors for the growth of the market. The high cost of treatment followed by government stringent regulation is considered as a major restraining factor which curbs the growth of the market. Increasing awareness in Asia Pacific countries is considered one of the major opportunities for the growth of the market during the forecast period.

In Drug type, the market is classified into sixtype’sSildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others. The Sildenafil Citrate (Viagra) accounts for the largest market shares of the Erectile Dysfunction market in the year 2019. VIAGRA works for men with erectile dysfunction (ED) by increasing blood flow to the penis so it can get and keep an erection hard enough for sex.  Results may vary from Person to Person. It’s been proven to help guys with all degrees of ED. VIAGRA usually starts to work within 30-60 minutes.

Based on Mode of Administration, the market is fragmented into two types: Oral Medications, Topical Medications, Injections, and Others. Oral medication Accounted for the largest market share and will remain the same within the forecasted year. The oral administration route is preferred over the various other administration routes of drug delivery due to the many advantages it exhibits. These advantages include safety, good patient compliance, and ease of ingestion, pain avoidance, and versatility to accommodate various types of drugs.

In terms of region, the market is classified into North America, Europe, Asia Pacific, Latin America and the Middle East, and Africa. In North America, the U.S. dominates the market. The patent expiry of leading drugs and increased adoption of alternative treatments are some of the factors responsible for the declining growth of the erectile dysfunction drugs market in the United States. Whereas, Asia Pacific region hits the highest growth of the market and the same will remain the forecasted year. The growth is due to India and China's Population demand.

Report Scope

Some of the leading players in the global market include

Apricus Biosciences, Bayer AG, Cristália, Eli Lilly and Company, Inc., Pfizer, Inc., Dong-A-Pharmaceutical Co., Ltd., S.K. Chemicals Co., Ltd., Vivus, Inc., Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc. and Others

The taxonomy of the Erectile Dysfunction Drugs Market by its scope and segmentation is as follows:

By Drug Type Segment Analysis

• Sildenafil Citrate (Viagra)
• Vardenafil (Levitra/ Staxyn)
• Tadalafil (Cialis)
• Udenafil (Zydena)
• Lodenafil Carbonate (Helleva)
• Stendra/ Spedra (Avanafil)
• Mirodenafil (Mvix)
• Others

By Mode of AdministrationSegment Analysis

• Oral Medications
• Topical Medications
• Injections
• Others

By Distribution ChannelSegment Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Online Sales

By Region Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• The Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com